People who reported having stressful jobs were 48 percent more likely to develop atrial fibrillation (AFib), according to a Swedish study published in the European Journal of Preventive Cardiology.

With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May 24 in Circulation.

Patients who required permanent pacemakers (PPMs) after transcatheter aortic valve replacement (TAVR) demonstrated lower survival rates and higher comorbidity burdens over a multiyear follow-up. However, they didn’t accumulate significantly greater healthcare costs, according to a study published online May 25 in JAMA Network Open.

A smartwatch algorithm reliably differentiated atrial fibrillation (AF) from sinus rhythm among patients scheduled for elective cardioversion, showing the technology’s potential to prevent unnecessary procedures.

One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.

Even for patients with intermittent atrial fibrillation (AFib), the amount of time spent in an arrhythmic state is strongly associated with an increased risk of stroke, researchers reported in JAMA Cardiology.

A His bundle pacing (HBP) strategy was associated with a significant reduction in hospitalizations for heart failure when compared to pacemaker implantation via the right ventricle, according to a study published online May 14 in the Journal of the American College of Cardiology.

Women who received catheter ablation in the FIRE AND ICE trial were 37 percent more likely than men to have a recurrence of atrial arrhythmia and 36 percent more likely to be rehospitalized for cardiovascular causes, according to an analysis published April 26 in Circulation: Arrhythmia and Electrophysiology.